These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27363060)
21. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data. Uijterwaal MH; Polman NJ; Witte BI; van Kemenade FJ; Rijkaart D; Berkhof J; Balfoort-van der Meij GA; Ridder R; Snijders PJ; Meijer CJ Int J Cancer; 2015 May; 136(10):2361-8. PubMed ID: 25345358 [TBL] [Abstract][Full Text] [Related]
22. Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). Frega A; Pavone M; Sesti F; Leone C; Bianchi P; Cozza G; Colombrino C; Lukic A; Marziani R; De Sanctis L; Delli Carpini G; Caserta D; Ciavattini A Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10672-10677. PubMed ID: 31858534 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of cervical cone biopsies for coexpression of p16INK4a and Ki-67 in epithelial cells. Reuschenbach M; Seiz M; von Knebel Doeberitz C; Vinokurova S; Duwe A; Ridder R; Sartor H; Kommoss F; Schmidt D; von Knebel Doeberitz M Int J Cancer; 2012 Jan; 130(2):388-94. PubMed ID: 21387293 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion. Waldstrøm M; Christensen RK; Ørnskov D Cancer Cytopathol; 2013 Mar; 121(3):136-45. PubMed ID: 22987560 [TBL] [Abstract][Full Text] [Related]
25. Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study. Fujii T; Saito M; Hasegawa T; Iwata T; Kuramoto H; Kubushiro K; Ohmura M; Ochiai K; Arai H; Sakamoto M; Motoyama T; Aoki D Int J Clin Oncol; 2015 Feb; 20(1):134-42. PubMed ID: 24744261 [TBL] [Abstract][Full Text] [Related]
26. Variability of pathologists' utilization of p16 and ki-67 immunostaining in the diagnosis of cervical biopsies in routine pathology practice and its impact on the frequencies of cervical intraepithelial neoplasia diagnoses and cytohistologic correlations. Singh C; Manivel JC; Truskinovsky AM; Savik K; Amirouche S; Holler J; Thyagarajan B; Gulbahce HE; Pambuccian SE Arch Pathol Lab Med; 2014 Jan; 138(1):76-87. PubMed ID: 24377814 [TBL] [Abstract][Full Text] [Related]
27. Association of human papillomavirus L1 capsid protein with koilocytosis, expression of p16, and Ki-67, and its potential as a prognostic marker for cervical intraepithelial neoplasia. Chen L; Sun MJ; Shi HY; He Q; Liu DG Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):139-45. PubMed ID: 24344500 [TBL] [Abstract][Full Text] [Related]
28. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838 [TBL] [Abstract][Full Text] [Related]
29. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I]. Wang R; Li X; Qian M; Niu J; You Z Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412 [TBL] [Abstract][Full Text] [Related]
30. Prospective evaluation of p16/Ki-67 dual-stained cytology for managing women with abnormal Papanicolaou cytology: PALMS study results. Bergeron C; Ikenberg H; Sideri M; Denton K; Bogers J; Schmidt D; Alameda F; Keller T; Rehm S; Ridder R; Cancer Cytopathol; 2015 Jun; 123(6):373-81. PubMed ID: 25891096 [TBL] [Abstract][Full Text] [Related]
31. Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology. Castle PE; Adcock R; Cuzick J; Wentzensen N; Torrez-Martinez NE; Torres SM; Stoler MH; Ronnett BM; Joste NE; Darragh TM; Gravitt PE; Schiffman M; Hunt WC; Kinney WK; Wheeler CM; ; Arch Pathol Lab Med; 2020 Jun; 144(6):725-734. PubMed ID: 31718233 [TBL] [Abstract][Full Text] [Related]
32. [Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection]. Wang HR; Liao GD; Jiang Y; Li YC; Qiao YL; Chen W Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1241-1245. PubMed ID: 28910940 [No Abstract] [Full Text] [Related]
33. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion. Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504 [TBL] [Abstract][Full Text] [Related]
34. The triage of low-grade cytological abnormalities by the immunocytological expression of cyclin-dependent kinase inhibitor p16INK4a versus Human Papillomavirus test: a real possibility to predict cervical intraepithelial neoplasia CIN2 or CIN2+. Stănculescu R; Brătilă E; Bauşic V; Vlădescu T Rom J Morphol Embryol; 2013; 54(4):1061-5. PubMed ID: 24399002 [TBL] [Abstract][Full Text] [Related]
35. Prognostic role of immunohistochemical overexpression of the p16 protein in women under the age of 35 and diagnosed with HSIL (CIN2) subjected to "cervix sparing" excision. Lukic A; Rossi S; Frega A; Ruscito I; Bianchi P; Nobili F; Caserta D; Vecchione A Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1261-1273. PubMed ID: 33629296 [TBL] [Abstract][Full Text] [Related]
36. p16 Immunohistochemistry in Colposcope-Directed and Random Cervical Biopsies of CIN2 and CIN3. Arvizo C; Chen Q; Du H; Wang C; Tang J; Yang B; Pretorius RG; Wu R; Belinson JL J Low Genit Tract Dis; 2016 Jul; 20(3):197-200. PubMed ID: 26855142 [TBL] [Abstract][Full Text] [Related]
37. Meta-analysis on the performance of p16/Ki-67 dual immunostaining in detecting high-grade cervical intraepithelial neoplasm. Sun M; Shen Y; Ren ML; Dong YM J Cancer Res Ther; 2018 Sep; 14(Supplement):S587-S593. PubMed ID: 30249873 [TBL] [Abstract][Full Text] [Related]
38. P16 and Ki-67 expression improves the diagnostic accuracy of cervical lesions but not predict persistent high risk human papillomavirus infection with CIN1. Zhong P; Li J; Gu Y; Liu Y; Wang A; Sun Y; Lu L Int J Clin Exp Pathol; 2015; 8(3):2979-86. PubMed ID: 26045807 [TBL] [Abstract][Full Text] [Related]
39. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study. Liu W; Gong J; Xu H; Zhang D; Xia N; Li H; Song K; Lv T; Chen Y; Diao Y; Jao J; Dai S; Zhao P; Yao Q Diagn Cytopathol; 2020 Jul; 48(7):635-644. PubMed ID: 32275355 [TBL] [Abstract][Full Text] [Related]
40. The predictive value of p16(INK4a) and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia. Guo M; Hu L; Baliga M; He Z; Hughson MD Am J Clin Pathol; 2004 Dec; 122(6):894-901. PubMed ID: 15539381 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]